Key Development This morning, August 10, 2026, the Ministry of Health (MOH) of Vietnam officially promulgated a landmark Circular detailing... Read more
Category: Uncategorized
Historic Vaccine Milestone: US FDA Grants Approval for Moderna’s mFLUSIVA® – The World’s First mRNA-Based Seasonal Influenza Vaccine
Key Development The U.S. Food and Drug Administration (FDA) has granted regulatory approval for mFLUSIVA® (mRNA-1010), developed by Moderna, Inc.... Read more
Outbreak Diagnostic Response: Roche Launches Two Novel PCR Cyclospora Test Panels as U.S. Foodborne Outbreak Escalates to Record Levels
Key Development Swiss healthcare giant Roche Holding AG (SIX: ROG) officially announced the commercial availability of two new PCR-based diagnostic... Read more
Consumer Health & Wellness M&A: Procter & Gamble (P&G) Executes $3.8 Billion Acquisition of Premium Supplement Brand Thorne HealthTech
Key Development Consumer goods giant Procter & Gamble Co. (NYSE: PG) has entered into a definitive agreement to acquire premium... Read more
HIV & PrEP Commercial Acceleration: Gilead Sciences Outperforms Q2 2026 Revenue Estimates at $7.8 Billion, Offsetting One-Time M&A Charges
Key Development American biopharmaceutical major Gilead Sciences, Inc. (NASDAQ: GILD) officially released its Q2 2026 financial readouts, generating total quarterly... Read more
Anti-Obesity Franchise Market Dynamics: Novo Nordisk Raises 2026 Outlook, Yet Shares Fall 6% as Oral Wegovy Sales Miss Consensus and CagriSema Trial Disappoints
Key Development Danish biopharmaceutical leader Novo Nordisk (OMX: NOVOb) released its Q2 2026 financial readouts, officially raising its full-year 2026... Read more
Post-COVID Restructuring Matrix: Pfizer Beats Q2 2026 Earnings Expectations, Targets Additional $2.5 Billion Cost Cuts, and Shifts M&A Strategy to Bolt-On Deals
Key Development American biopharmaceutical giant Pfizer Inc. (NYSE: PFE) has officially released its Q2 2026 financial readouts, outperforming Wall Street... Read more
Healthcare Administrative Modernization: Ministry of Health Slashes 40% of Pharmaceutical & Cosmetic Licensing Procedures, Expanding Full-End Digital Services and Decentralized Governance
Key Development According to official performance reports released on August 4, 2026, by the Drug Administration of Vietnam (DAV), Ministry... Read more
Illegal Cosmetics Manufacturing Bust: Authorities Seize Over 3.4 Tons of Uncertified Whitening Creams and Industrial Processing Equipment in Gia Lai
Key Development Market Surveillance authorities in Gia Lai Province have officially confirmed the execution of an emergency raid, discovering and... Read more









